Furthermore, the use of the CB2 agonist HU308 for three months as drug-enriched pellets induced no effect on HFD-induced obesity, except for reduced macrophage polarization in the liver and adipose tissue [34]. The gene discussed is CNR2; the disease is obesity disorder.